Found "Health Policies": 996 results
Report: Unit for Health Evidence and Policy (UHEP) Second Stakeholder Consultation and HTA Topic Prioritisation Workshop
This mission report summarises the activities and discussions during the second meeting of the Unit for Health Evidence and Policy (UHEP), held on September 1st, 2022. This meeting aimed to promote the understanding of Health Technology Assessment (HTA) topic prioritisation in Lao PDR and sharing Th
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? (2013)
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?
Thavorncharoensap M1, Teerawattananon Y, Natanant S, Kulpeng W, Yothasamut J, Werayingyong P
1Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Thailand ; Heal
Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context? (2013)
Cost-utility analysis of 10- and 13-valent pneumococcal conjugate vaccines: Protection at what price in the Thai context?
Wantanee Kulpenga, b, , , , Pattara Leelahavaronga, , Waranya Rattanavipaponga, , Vorasith Sornsrivichaib, , Henry C. Baggettc, , Aronrag Meeyaia, d, , , Warunee Punpaniche, ,
Evidence-informed policy formulation the case of the voucher scheme for maternal and child health in Myanmar (2014)
Yot Teerawattananon,1 Sripen Tantivess,1 Pitsaphun Werayingyong,1
Pritaporn Kingkaew,1 Nilar Tin,2 San San Aye,3 Phone Myint3
Abstract
Introduction: In 2010, with financial support from the Global Alliance for Vaccine and Immunization’s Health System Strengthening programme, the Government of
Accounting for Technical, Ethical, and Political Factors in Priority Setting (2016)
Katharina Kieslich1,*, Jesse B. Bump2 , Ole Frithjof Norheim3 , Sripen Tantivess4 and Peter Littlejohns1 1 Faculty of Life Sciences & Medicine, Division of Health and Social Care Research, King’s College London, London, UK 2 Department of Global Health and Population, Harvard T. H. Chan School o
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh (2016)
Background
Economic evaluation has been implemented to inform policy in many areas, including coverage decisions, technology pricing, and the development of clinical practice guidelines. However, there are barriers to evidence-based policy in low- and middle-income countries (LMICs) that include li
Leaving No One Behind: Participatory Technology Appraisal as a Platform for Agenda Setting to Address Disparities in Access to Health Services in Thailand.
Abstract
OBJECTIVES:
This article discusses how participatory technology appraisal as part of the Universal Coverage Scheme (UCS) in Thailand contributes to improving access to essential health services among vulnerable populations.
METHODS:
Document review was conducted on health technology
How can health technology assessment support our response to public health emergencies?
Public health emergencies (PHEs), such as the COVID-19 crisis, are threats to global health and public order. We recommend that countries bolster their PHE responses by investing in health technology assessment (HTA), defined as a systematic process of gathering pertinent information on and evaluati
Application of HTA Research on Policy Decision-Making (2014)
Sitaporn Youngkong MSc, PhD*
* Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand
This article provides an overview of the potential uses of health technology assessment (HTA) in health technology or health intervention-related policy decision-
Formulating policy recommendations to alleviate health problems among people living around industrial areas in Thailand: a case study of leukemia (under research for development of the health benefit package under the universal coverage scheme)
This study is a part of the research in “Research for development of health benefit package under universal coverage scheme”. This study aims to estimate social costs of health impact of people living inside and around industrial areas who risked acute myeloid leukemia (AML), in cases whereby AML was caused by benzene exposure. The result point
10 / Page